KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Assets (2016 - 2025)

Novavax has reported Other Non-Current Assets over the past 16 years, most recently at $87.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $87.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $87.5 million (changed N/A YoY), and the annual figure for FY2025 was $87.5 million, changed.
  • Other Non-Current Assets for Q4 2025 was $87.5 million at Novavax, down from $107.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for NVAX hit a ceiling of $107.7 million in Q3 2025 and a floor of $1.5 million in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $28.5 million (2022), compared with a mean of $30.5 million.
  • Biggest five-year swings in Other Non-Current Assets: crashed 50.23% in 2021 and later skyrocketed 1213.83% in 2022.
  • Novavax's Other Non-Current Assets stood at $24.3 million in 2021, then increased by 17.2% to $28.5 million in 2022, then rose by 23.5% to $35.2 million in 2023, then decreased by 13.12% to $30.5 million in 2024, then soared by 186.48% to $87.5 million in 2025.
  • The last three reported values for Other Non-Current Assets were $87.5 million (Q4 2025), $107.7 million (Q3 2025), and $21.4 million (Q2 2025) per Business Quant data.